Concepedia

Donna Griebel

DG

12

Publications

733

Citations

11

H-Index

1997

Active since

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

National Institutes of Health

Health Canada

Pharmaceuticals and Medical Devices Agency

Donna Griebel is an author at United States Food and Drug Administration specializing in medicine, cancer therapeutics, and pharmacotherapy.

Top concepts

Publications per year

1997–2016

12

Publications

12

Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.

Mark D. Rothmann, Jogarao Gobburu, Gabriel J. Robbie et al. · PubMed · 2002 · 240 citations

FDA Drug Approval Summaries: Oxaliplatin

Amna Ibrahim, Steven Hirschfeld, Martin H. Cohen et al. · The Oncologist · 2004 · 171 citations · Full text

Population Pharmacokinetic–Based Dosing of Intravenous Busulfan in Pediatric Patients

Brian Booth, Atiqur Rahman, Ramzi Dagher et al. · The Journal of Clinical Pharmacology · 2006 · 97 citations

, , +11

U.S. Food and Drug Administration Drug Approval Summaries: Imatinib Mesylate, Mesna Tablets, and Zoledronic Acid

Martin H. Cohen, Ramzi Dagher, Donna Griebel et al. · The Oncologist · 2002 · 56 citations · Full text

, , +16

Evolution of Clinical Trials for Irritable Bowel Syndrome: Issues in End Points and Study Design

Ann Marie Trentacosti, Ruyi He, Laurie B. Burke et al. · The American Journal of Gastroenterology · 2010 · 39 citations

Rows per page

1–5 of 12